Neuropathic pain management in chronic laminitis

Veterinary Clinics of North America - Equine Practice

Volumn 26, Issue 2, 2010, Pages 315-337

  Driessen, Bernd ^a,b   Bauquier, Sébastien H ^c   Zarucco, Laura ^d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA SCHOOL OF VETERINARY MEDICINE   (United States)

^d UNIVERSITY OF TURIN   (Italy)

Author keywords

Analgesics; Gabapentin; Horse; Laminitis; Neuropathic pain; Nonsteroidal antiinflammatory drugs

Indexed keywords

ANIMAL; ANIMAL DISEASE; FOOT DISEASE; HOOF AND CLAW; HORSE; HORSE DISEASE; INFLAMMATION; NEURALGIA; PAIN; REVIEW;

ANIMALS; FOOT DISEASES; HOOF AND CLAW; HORSE DISEASES; HORSES; INFLAMMATION; NEURALGIA; PAIN;

ANIMALIA; EQUIDAE;

EID: 77955490574     PISSN: 07490739     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cveq.2010.04.002     Document Type: Review

References (153)

1. Moore RM. Laminitis vision: 20/20 by 2020. In: Proceedings of the Fifth International Equine Conference on Laminitis and Diseases of the Foot. Palm Beach (FL); 2009. p. 15-20.
2. Orsini J., Galantino-Homer H., Pollitt C.C. Laminitis in horses: through the lens of systems theory. J Equine Vet Sci 2009, 29(2):105-114.
3. Hood D.M. Laminitis in the horse. Vet Clin North Am Equine Pract 1999, 15(2):287-294.
4. Pollitt C.C. Equine laminitis. Clin Tech Equine Pract 2004, 3(1):34-44.
5. Rendle D. Equine laminitis 1. Management in the acute stage. In Pract 2006, 28:434-443.
6. Fontaine G.L., Belknap J.K., Allen D., et al. Expression of interleukin-1β in the digital laminae of horses in the prodromal stage of experimentally induced laminitis. Am J Vet Res 2001, 62(5):714-720.
7. Waguespack R.W., Cochran A., Belknap J.K. Expression of the cyclooxygenase isoforms in the prodromal stage of black walnut-induced laminitis in horses. Am J Vet Res 2004, 65(12):1724-1729.
8. Blikslager A.T., Yin C.L., Cochran A.M., et al. Cyclooxygenase expression in the early stages of equine laminitis: a cytologic study. J Vet Intern Med 2006, 20(5):1191-1196.
9. Noschka E., Moore J.N., Peroni J.F., et al. Thromboxane and isoprostanes as inflammatory and vasoactive mediators in black walnut heartwood extract induced equine laminitis. Vet Immunol Immunopathol 2009, 129(3/4):200-210.
10. Pollitt C.C. Basement membrane pathology: a feature of acute equine laminitis. Equine Vet J 1996, 28(1):38-46.
11. Pollitt C.C., Daradka M. Equine laminitis basement membrane pathology: loss of type IV collagen, type VII collagen and laminin immunostaining. Equine Vet J Suppl 1998, 26:139-144.
12. Johnson P.J., Tyagi S.C., Katwa L.C., et al. Activation of extracellular matrix metalloproteinases in equine laminitis. Vet Rec 1998, 14(2):392-396.
13. Johnson P.J., Kreeger J.M., Keeler M., et al. Serum markers of lamellar basement membrane degradation and lamellar histopathological changes in horses affected with laminitis. Equine vet J 2000, 32(6):462-468.
14. Kyaw-Tanner M., Pollitt C.C. Equine laminitis: increased transcription of matrix metalloproteinase-2 (MMP-2) occurs during the developmental phase. Equine vet J 2004, 36(3):221-225.
15. Yaksh TL. Pain Management I: basic mechanisms in pain processing. In: Proceedings of the Fifth International Equine Conference on Laminitis and Diseases of the Foot. Palm Beach (FL); 2009. p. 84-5.
16. Yaksh TL. Pain Management II: current thinking on the mechanisms underlying laminitic pain. In: Proceedings of the Fifth International Equine Conference on Laminitis and Diseases of the Foot. Palm Beach (FL); 2009. p. 86-8.
17. Bowker R.M., Brewer A.M., Vex K.B.A., et al. Sensory receptors in the equine foot. Am J Vet Res 1993, 54(11):1840-1844.
18. Van Wulfen K.K., Bowker R.M. Evaluation of tachykinins and their receptors to determine sensory innervation in the dorsal hoof wall and insertion of the distal sesamoidean impar ligament and deep digital flexor tendon on the distal phalanx in healthy feet of horses. Am J Vet Res 2002, 63(2):222-228.
19. Buda S., Budras K.D. Segment specific nerve supply of the equine hoof. Pferdeheilkunde 2005, 21(4):280-284.
20. Molyneux G.S., Haller C.J., Mogg K., et al. The structure, innervation and location of arteriovenous anastomoses in the equine foot. Equine vet J 1994, 26(4):305-312.
21. Morgan S.J., Grosenbaugh D.A., Hood D.M. The pathophysiology of chronic laminitis. Vet Clin North Am Equine Pract 1999, 15(2):395-417.
22. Giordano J. The neurobiology of pain. Pain management: a practical guide for clinicians 2001, 1089-1100. CRC Press, Boca Raton (FL). 6th edition. R.S. Weiner (Ed.).
23. Orsini JA, Galantino-Homer H, Pollitt CC. Hot topics at the fourth international equine conference on laminitis and diseases of the foot. In: Large animal proceedings of the North American Veterinary Conference. Orlando (FL); 2009. p. 216-7.
24. Jones E., Viñuela-Fernandez I., Eager R.A., et al. Neuropathic changes in equine laminitis pain. Pain 2007, 132:321-331.
25. Owens J.G., Kamerling S.G., Keowen M.L. Eicosanoid concentrations in digital venous blood from horses with chronic laminitis. Am J Vet Res 1995, 56(4):507-510.
26. Moore J.N., Allen D. The pathophysiology of acute laminitis. Vet Med 1996, 10:936-939.
27. Doubell T.P., Mannion R.J., Wolf C.J. The dorsal horn: state dependent sensory processing, plasticity, and the generation of pain. Textbook of pain 1999, 165-182. Churchill-Livingstone, New York. 4th edition. P.D. Wall, R. Melzak (Eds.).
28. Klusakova I., Dubovy P. Experimental models of peripheral neuropathic pain based on traumatic nerve injuries - an anatomical perspective. Ann Anat 2009, 191(3):248-259.
29. Costigan M., Scholz J., Woolf C.J. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci 2009, 32:1-32.
30. Driessen B. Pain: from sign to disease. Clin Tech Equine Pract 2007, 6(2):120-125.
31. Kawasaki Y., Xu Z.Z., Wang X., et al. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med 2008, 14(3):331-336.
32. Driessen B., Zarucco L. Pain: from diagnosis to effective treatment. Clin Tech Equine Pract 2007, 6(2):126-134.
33. Obel N. Studies on the histopathology of acute laminitis. Uppsala (Sweden): Almqvist and Wiksells Boktryckteri AK; 1948 [dissertation].
34. American Association of Equine Practioners. Definition and classification of lameness. In: American Association of Equine Practioners: guide for veterinary service and judging of equestrian events. 4th edition. Lexington (KY); 1991. p. 19.
35. Dutton D.W., Lashnits K.J., Wegner K. Managing severe hoof pain in a horse using multimodal analgesia and a modified composite pain score. Equine Vet Educ 2009, 21:37-43.
36. Aviad A.D. The use of the standing force plate as a quantitative measure of equine lameness. J Equine Vet Sci 1988, 8:460-462.
37. Hood D.M., Wagner I.P., Taylor D.D., et al. Voluntary limb-load distribution in horses with acute and chronic laminitis. Am J Vet Res 2001, 66(9):1393-1398.
38. Hunt R.J. Diagnosing and treating chronic laminitis in horses. Vet Med 1996, 91(11):1025-1032.
39. Brumbaugh G.W., Sumano Lopez H., Hoyos Sepulveda M.L. The pharmacologic basis for the treatment of developmental and acute laminitis. Vet Clin North Am Equine Pract 1999, 15(2):345-362.
40. Sumano Lopez H., Hoyos Sepulveda M.L., Brumbaugh G.W. Pharmacologic and alternative therapies for the horse with chronic laminitis. Vet Clin North Am Equine Pract 1999, 15(2):495-516.
41. Parks A.H. Treatment of acute laminitis. Equine vet Educ 2003, 15(5):273-280.
42. Parks A., O'Grady S.E. Chronic laminitis: current treatment strategies. Vet Clin North Am Equine Pract 2003, 19(2):393-416.
43. Belknap JK. Treatment of the acute laminitis case. In: Large animal proceedings of the North American Veterinary Conference. Orlando (FL); 2006. p. 76-80.
44. Belknap JK. Treatment of the chronic laminitis case. In: Large animal proceedings of the North American Veterinary Conference. Orlando (FL); 2006. p. 79-80.
45. Piccot-Crezollet C., Olive J., Cadore J.L. Diagnostic and therapeutic approaches in the face of acute laminitis in horses. Le Nouveau Praticien Veterinaire - Equine 2008, 5(17):17-23.
46. Moore R.M. Evidence-based treatment for laminitis - what works?. J Equine Vet Sci 2008, 28(3):176-179.
47. Moyer W, Schumacher J, Schumacher J, et al. Are drugs effective treatment for horses with acute laminitis? In: Proceedings of the 54th Annual Convention of the American Association of Equine Practioners, San Diego (CA); 2008. p. 337-40.
48. Divers TJ. Medical treatment of acute laminitis. In: Large animal proceedings of the North American Veterinary Conference. Orlando (FL); 2009. p. 174.
49. Siddall P.J., Cousins M.J. Persistent pain as a disease entity: implications for clinical management. Anesth Analg 2004, 99:510-520.
50. Hansen N., Buchner F., Haller J., et al. Evaluation using hoof wall strain gauges of a therapeutic shoe and a hoof cast with a heel wedge as potential supportive therapy for horses with laminitis. Vet Surg 2005, 34:630-636.
51. Morrison S. Rehabilitating the laminitic foot. In: Large animal proceedings of the North American Veterinary Conference. Orlando (FL); 2008. p. 186-9.
52. Hunt R.J., Allen D., Baxter G.M., et al. Mid-metacarpal deep digital flexor tenotomy in the management of refractor laminitis in horses. Vet Surg 1991, 20(1):15-20.
53. Vasko K.A., Spauchus A., Lowry M. Laminitis treatment with electrotherapy. Equine Pract 1986, 8(4):28-31.
54. Carter D.W., Renfroe J.B. A novel approach to the treatment and prevention of laminitis: botulinum toxin type A for the treatment of laminitis. J Equine Vet Sci 2009, 29(7):595-600.
55. Galluzzi K.E. Management of neuropathic pain. J Am Osteopath Assoc 2005, 105(9):S12-S19.
56. Finnerup N.B., Otto M., McQuay H.J., et al. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005, 118(3):289-305.
57. Dworkin R.H., O'Connor A.B., Backonja M., et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007, 132(3):237-251.
58. O'Connor A.B., Dworkin R.H. Treatment of neuropathic pain: an overview of recent guidelines. Am J Med 2009, 122(Suppl 10):S22-S32.
59. McGeeney B.E. Pharmacological management of neuropathic pain in older adults: an update on peripherally and centrally acting agents. J Pain Symptom Manage 2009, 38(Suppl 2):S15-S27.
60. Clark J.O., Clark T.P. Analgesia. Vet Clin North Am Equine Pract 1999, 15(3):705-723.
61. Pollitt C.C. Medical therapy of laminitis. Diagnosis and management of lameness in the horse 2003, 329-332. Saunders, St. Louis (MO). M.W. Ross, S.J. Dyson (Eds.).
62. Rouzer C.A., Marnett L.J. Structural and functional differences between cyclooxygenases: fatty acid oxygenases with a critical role in cell signaling. Biochem Biophys Res Commun 2005, 338(1):34-44.
63. Yaksh T.L., Dirig D.M., Conway C.M., et al. The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1. J Neurosci 2001, 21(6):5847-5853.
64. Urdaneta A., Siso A., Urdaneta B., et al. Lack of correlation between the central anti-nociceptive and peripheral anti-inflammatory effects of selective COX-2 inhibitor parecoxib. Brain Res Bull 2009, 80(1-2):56-61.
65. Simon L.S. Biology and toxic effects of nonsteroidal anti-inflammatory drugs. Curr Opin Rheumatol 1998, 10(3):153-158.
66. Blikslager A. Role of NSAIDs in the management of pain in horses. In: Proceedings of the American Association of Equine Practioners-Focus Meeting. Raleigh (NC); 2009. p. 218-23.
67. Divers T.J. COX inhibitors: Making the best choice for the laminitic case. J Equine Vet Sci 2008, 28(6):367-369.
68. Cryer B., Feldman M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med 1998, 104(5):413-421.
69. Owens J.G., Kamerling S.G., Stanton S.R., et al. Effects of ketoprofen and phenylbutazone on chronic hoof pain and lameness in the horse. Equine Vet J 1995, 27(4):296-300.
70. Ossipov M.H., Jerussi T.P., Ren K., et al. Differential effects of spinal (R)-ketoprofen and (S)-ketoprofen against signs of neuropathic pain and tonic nociception: evidence for a novel mechanism of action of (R)-ketoprofen against tactile allodynia. Pain 2000, 87(2):193-199.
71. Diaz-Reval M.I., Ventura-Martinez R., Deciga-Campos M., et al. Evidence for a central mechanism of action of S-(+)-ketoprofen. Eur J Pharmacol 2004, 483(2-3):241-248.
72. Whay H.R., Webster A.J.F., Waterman-Pearson A.E. Role of ketoprofen in the modulation of hyperalgesia associated with lameness in dairy cattle. Vet Rec 2005, 157(23):729-733.
73. Moses V.S., Bertone A.L. Nonsteroidal anti-inflammatory drugs. Vet Clin North Am Equine Pract 2002, 18(1):21-37.
74. Snow D.H., Douglas T.A., Thompson H., et al. Phenylbutazone toxicosis in equidae: a biochemical and pathophysiological study. Am J Vet Res 1981, 42(10):1754-1759.
75. Doucet M.Y., Bertone A.L., Hendrickson D., et al. Comparison of efficacy and safety of paste formulations of firocoxib and phenylbutazone in horses with naturally occurring osteoarthritis. J Am Vet Med Assoc 2008, 232(1):91-97.
76. MacAllister C.G., Morgan S.J., Borne A.T., et al. Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses. J Am Vet Med Assoc 1993, 202(1):71-77.
77. Bennett R.C., Steffey E.P. Use of opioids for pain and anesthetic management in horses. Vet Clin North Am Equine Pract 2002, 18(1):46-60.
78. Driessen B. Pain: systemic and local/regional drug therapy. Clin Tech Equine Pract 2007, 6(2):135-144.
79. Valverde A., Gunkel C. Pain management in horses and farm animals. J Vet Emerg Crit Care 2005, 15(4):295-307.
80. Angst M.S. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 2006, 104(3):570-587.
81. Chu L.F., Angst M.S., Clark D. Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin J Pain 2008, 24(6):479-496.
82. Silverman S.M. Opioid induced hyperalgesia: clinical implications for the pain practitioner. Pain Physician 2009, 12(3):679-684.
83. Fishbain D.A.A. Do opioids induce hyperalgesia in humans? An evidence-based structured review. Pain Med 2009, 10(5):829-839.
84. Sellon D.C., Monroe V.L., Roberts M.C., et al. Pharmacokinetics and adverse effects of butorphanol administered by single intravenous injection or continuous intravenous infusion in horses. Am J Vet Res 2001, 62(2):183-189.
85. Sellon D.C., Roberts M.C., Blikslager A.T., et al. Effects of continuous rate intravenous infusion of butorphanol on physiologic and outcome variables in horses after celiotomy. J Vet Intern Med 2004, 18(4):555-563.
86. Wegner K, Franklin RP, Long MT, et al. How to use fentanyl transdermal patches for analgesia in horses. In: Proceedings of the 48th Annual Convention of the American Association of Equine Practitioners. Orlando (FL); 2002. p. 291-4.
87. Thomasy S.M., Slovis N., Maxwell L.K., et al. Transdermal fentanyl combined with non-steroidal anti-inflammatory drugs for analgesia in horses. J Vet Intern Med 2004, 18(4):550-554.
88. Orsini J.A., Moate P.J., Kuersten K., et al. Pharmacokinetics of fentanyl delivered transdermally in healthy adult horses - variability among horses and its clinical implications. J Vet Pharmacol Ther 2006, 29(6):539-546.
89. Carregaro A.B., Luna S.P., Mataqueiro M.I., et al. Effects of buprenorphine on nociception and spontaneous locomotor activity in horses. Am J Vet Res 2007, 68(3):246-250.
90. Walker A.F. Sublingual administration of buprenorphine for long-term analgesia in the horse. Vet Rec 2007, 160(23):808-809.
91. Mao J., Chen L.L. Systemic lidocaine for neuropathic pain relief. Pain 2000, 87(1):7-17.
92. Malone E., Graham L. Management of gastrointestinal pain. Vet Clin Equine Pract 2002, 18(1):133-158.
93. Driessen B. Intravenous lidocaine infusion in balanced anaesthesia for abdominal surgery: update and clinical experiences. Pferdeheilkunde 2005, 21(2):133-141.
94. Murrell J.C., White K.L., Johnson C.B., et al. Investigation of the EEG effects of intravenous lidocaine during halothane anaesthesia in ponies. Vet Anaesth Analg 2005, 32(4):212-221.
95. Robertson S.A., Sanchez L.C., Merritt A.M., et al. Effect of systemic lidocaine on visceral and somatic nociception in conscious horses. Equine vet J 2005, 37(2):122-127.
96. Feary D.J., Mama K.R., Wagner A.E., et al. Influence of general anaesthesia on pharmacokinetics of intravenous lidocaine infusion in horses. Am J Vet Res 2005, 66(4):574-580.
97. Gottrup H., Bach F.W., Juhl G., et al. Differential effect of ketamine and lidocaine on spontaneous and mechanical evoked pain in patients with nerve injury pain. Anesthesiology 2006, 104(3):527-536.
98. Gormsen L., Finnerup N.B., Almqvist P.M., et al. The efficacy of the AMPA receptor antagonist NS1209 and lidocaine in nerve injury pain: a randomized, double-blind, placebo-controlled, three-way crossover study. Anesth Analg 2009, 108(4):1311-1319.
99. Meyer G.A., Lin H.C., Hanson R.R., et al. Effects of intravenous lidocaine overdose on cardiac electrical activity and blood pressure in the horse. Equine vet J 2001, 33(5):434-437.
100. De Solis C.N., McKenzie H.C. Serum concentrations of lidocaine and its metabolites MEGX and GX during and after prolonged intravenous infusion of lidocaine in horses after colic surgery. J Equine Vet Sci 2007, 27(9):398-404.
101. Dickey E.J., McKenzie H.C., Brown K.A., et al. Serum concentrations of lidocaine and its metabolites after prolonged infusion in healthy horses. Equine vet J 2008, 40(4):348-352.
102. Woolf C.J., Wiesenfeld-Hallin Z. The systemic administration of local anaesthetics produces a selective depression of C-afferent fibre evoked activity in the spinal cord. Pain 1985, 23(4):361-374.
103. Ness T. Intravenous lidocaine inhibits visceral nociceptive reflexes and spinal neurons in the rat. Anesthesiology 2000, 92(6):1685-1691.
104. Lauretti G.R. Mechanisms of analgesia of intravenous lidocaine. Revista Brasileira de Anestesiologia 2008, 58(3):280-286.
105. Abram S.E., Yaksh T.L. Systemic lidocaine blocks nerve injury-induced hyperalgesia and nociceptor-driven spinal sensitization in the rat. Anesthesiology 1994, 80(2):383-391.
106. Koppert W., Dern S.K., Sittl R., et al. New model of electrically evoked pain and hyperalgesia in human skin: the effects of intravenous alfentanil, S(+)-ketamine, and lidocaine. Anesthesiology 2001, 95(2):395-402.
107. Attal N., Rouaud J., Brasseur L., et al. Systemic lidocaine in pain due to peripheral nerve injury and predictors of response. Neurology 2004, 62(2):218-225.
108. Taniguchi T., Shibata K., Yamamoto K., et al. Lidocaine attenuates the hypotensive and inflammatory responses to endotoxemia in rabbits. Crit Care Med 1996, 24(4):642-646.
109. Hollmann M.W., Durieux M.E. Local anesthetics and the inflammatory response: a new therapeutic indication?. Anesthesiology 2000, 93(3):858-875.
110. Brianceau P., Chevalier H., Karas A., et al. Intravenous lidocaine and small-intestinal size, abdominal fluid, and outcome after colic surgery in horses. J Vet Intern Med 2002, 16(6):736-741.
111. Cook V.L., Jones Shults J., McDowell M.R., et al. Attenuation of ischaemic injury in the equine jejunum by administration of systemic lidocaine. Equine vet J 2008, 40(4):353-357.
112. Cook V.L., Jones Shults J., McDowell M.R., et al. Anti-inflammatory effects of intravenously administered lidocaine hydrochloride on ischemia-injured jejunum in horses. Am J Vet Res 2009, 70(10):1259-1268.
113. Cook V.L., Neuder L.E., Blikslager A.T., et al. The effect of lidocaine on in vitro adhesion and migration of equine neutrophils. Vet Immunol Immunopathol 2010, 129(1-2):137-142.
114. Williams J.M., Lin Y.J., Loftus J.P., et al. Effect of intravenous lidocaine administration on laminar inflammation in the black walnut extract model of laminitis. Equine Vet J 2010, 42(3):261-269.
115. Taylor C.P. The biology and pharmacology of calcium channel α2-δ proteins. CNS Drug Rev 2004, 10(2):183-188.
116. Dixit R.K., Bhargava V.K. Neurotransmitter mechanisms in gabapentin antinociception. Pharmacology 2002, 65(4):198-203.
117. Sills G.J. The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol 2006, 6:108-113.
118. Luo Z.D., Chaplan S.R., Higuera E.S., et al. Upregulation of dorsal root ganglion α2δ calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J Neurosci 2001, 21(6):1868-1875.
119. Newton R.A., Bingham S., Case P.C., et al. Dorsal root ganglion neurons show increased expression of the calcium channel α2δ - 1 subunit following partial sciatic nerve injury. Brain Res Mol Brain Res 2001, 95(1-2):1-8.
120. Maneuf Y.P., Luo Z.D., Lee K. α2δ and the mechanism of action of gabapentin in the treatment of pain. Semin Cell Dev Biol 2006, 17(5):565-570.
121. Harding L.M., Kristensen J.D., Baranowski A.P. Differential effects of neuropathic analgesics on wind-up-like pain and somatosensory function in healthy volunteers. Clin J Pain 2005, 21(2):127-132.
122. Arendt-Nielsen L., Brøndum Frøkjær J., Staahl C., et al. Effects of gabapentin on experimental somatic pain and temporal summation. Reg Anesth Pain Med 2007, 32(5):382-388.
123. Gilron I. Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: current evidence and future directions. Curr Opin Anesthesiol 2007, 20:456-472.
124. Ripamonti C., Dickerson E.D. Strategies for the treatment of cancer pain in the new millennium. Drugs 2001, 61(7):955-977.
125. Van Elstraete A.C., Sitbon P., Mazoit J.X., et al. Gabapentin prevents delayed and long-lasting hyperalgesia induced by fentanyl in rats. Anesthesiology 2008, 108(3):484-494.
126. Davis J.L., Posner L.P., Elce Y. Gabapentin for the treatment of neuropathic pain in a pregnant horse. J Am Vet Med Assoc 2007, 231(5):755-758.
127. Dirikolu L., Dafalla A., Ely K.J., et al. Pharmacokinetics of gabapentin in horses. J Vet Pharmacol Ther 2008, 31(2):175-177.
128. Terry R, McDonnell SM, van Eps AW, et al. Pharmacokinetic profile and behavioral effects of gabapentin in the horse. J Vet Pharmacol Ther, in press.
129. Eckhardt K., Ammon S., Hofmann U., et al. Gabapentin enhances the analgesic effect of morphine in healthy volunteers. Anesth Analg 2000, 91(1):185-191.
130. Rison R.A., Stanton P.K. Long-term potentiation and N-methyl-D-aspartate receptors: foundations of memory and neurologic disease?. Neurosci Biobehav Rev 1995, 19(4):533-552.
131. Mori H., Mishina M. Structure and function of the NMDA receptor channel. Neuropharmacol 1995, 34(10):1219-1237.
132. Orser B.A., Pennefather P.S., MacDonald J.F. Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors. Anesthesiology 1997, 86(4):903-917.
133. Wong C.S., Cherng C.H., Ho S.T. Clinical applications of excitatory amino acid antagonists in pain management. Acta Anaesthesiol Sin 1995, 33(4):227-232.
134. Schmid R.L., Sandler A.N., Katz J. Use and efficacy of low-dose ketamine in the management of acute postoperative pain: a review of current techniques and outcomes. Pain 1999, 82(2):111-125.
135. Hocking G., Cousins M.J. Ketamine in chronic pain management: an evidence-based review. Anesth Analg 2003, 97(6):1730-1739.
136. Richebe P., Rivat C., Rivalan B. Low doses ketamine: antihyperalgesic drug, non-analgesic. Ann Fr Anesth Reanim 2005, 24(11-12):1349-1359.
137. Strigo I.A., Duncan G.H., Bushnell C., et al. The effects of racemic ketamine on painful stimulation of skin and viscera in human subjects. Pain 2005, 113(3):255-264.
138. De Kock M.F., Lavand'homme P.M. The clinical role of NMDA receptor antagonists for the treatment of postoperative pain. Best Pract Res Clin Anaesthesiol 2007, 21(1):85-98.
139. Visser E., Schug S.A. The role of ketamine in pain management. Biomed Pharmacother 2006, 60(7):341-348.
140. Fielding C.L., Brumbaugh G.W., Matthews N.S., et al. Pharmacokinetics and clinical effects of a subanesthetic continuous rate infusion of ketamine in awake horses. Am J Vet Res 2006, 67(9):1484-1490.
141. Lankveld D.P.K., Driessen B., Soma L.R., et al. Pharmacodynamic effects and pharmacokinetic profile of a long-term continuous rate infusion of racemic ketamine in healthy conscious horses. J Vet Pharmacol Therap 2006, 29(6):477-488.
142. Levionnois OL, Menge M, Thormann W. Effect of ketamine on the limb withdrawal reflex evoked by transcutaneous electrical stimulation in ponies anaesthetised with isoflurane. Vet J, in press [Available online September 12, 2009].
143. Matthews NS, Fielding CI, Swinebroad E. How to use a ketamine constant rate infusion in horses for analgesia. In: Proceedings of the 50th Annual Convention of the American Association of Equine Practitioners. Denver (CO); 2004. p. 1431.
144. Suter M.R., Papaloizos M., Berde C.B., et al. Development of neuropathic pain in the rat spared nerve injury model is not prevented by a peripheral nerve block. Anesthesiology 2003, 99(6):1402-1408.
145. Xie W., Strong J.A., Meij J.T., et al. Neuropathic pain: early spontaneous afferent activity is the trigger. Pain 2005, 116(3):243-256.
146. Reuben S.S., Buvanendran A. Preventing the development of chronic pain after orthopaedic surgery with preventive multimodal analgesic techniques. J Bone Joint Surg Am 2007, 89(6):1343-1358.
147. Beloeil H., Gentili M., Benhamou D., et al. The effect of a peripheral block on inflammation-induced prostaglandin E2 and cyclooxygenase expression in rats. Anesth Analg 2009, 109(3):943-950.
148. Estebe J.P., Gentili M.E., Le Corre P., et al. Sciatic nerve block with bupivacaine-loaded microspheres prevents hyperalgesia in an inflammatory animal model. Can J Anaesth 2002, 49(7):690-693.
149. Driessen B., Scandella M., Zarucco L. Development of a technique for continuous perineural blockade of the palmar nerves in the distal equine thoracic limb. Vet Anaesth Analg 2008, 35:432-448.
150. Zarucco L., Driessen B., Scandella M., et al. Continuous perineural block of the palmar nerves: a new technique for pain relief in the distal equine forelimb. Clin Tech Equine Pract 2007, 6(2):154-164.
151. Zarucco L., Scandella M., Seco O., et al. Ultrasound-guided technique for continuous ulnar and median nerve blockade in the horse. Vet Surg 2008, 37(6):E34.
152. Natalini C.C., Driessen B. Epidural and spinal anesthesia and analgesia in the equine. Clin Tech Equine Pract 2007, 6(2):144-153.
153. Leise B.S., Fugler L.A., Stokes A.M., et al. Effects of intramuscular administration of acepromazine on palmar digital blood flow, palmar digital arterial pressure, transverse facial arterial pressure, and packed cell volume in clinically healthy, conscious horses. Vet Surg 2007, 36(8):717-723.